https://www.selleckchem.com/pr....oducts/danicamtiv-my
Estimated rate of local control at twelve months was 92%. Three patients (5%) experienced acute grade 2 toxicity. Two patients (4%) continued to suffer from chronic grade 1 skin toxicity at 12 months post-radiotherapy (RT), with an additional two patients (4%) experiencing chronic grade 2 skin toxicity. Forty-nine lesions (92%) were found to have a good or excellent cosmetic outcome with complete tumor remission. CT-based flap applicator brachytherapy is a valid treatment option for patients with NMSC of the face. This modali
Like
Comment
Share
